DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Baclofen is a drug marketed by Emerald Intl Ltd, Maia Pharms Inc, Mylan Labs Ltd, Aurobindo Pharma Ltd, Beximco Pharms Usa, Eywa Pharma, Impax, Innogenix, Ivax Sub Teva Pharms, Kartha, Lannett Co Inc, Mylan, Mylan Pharms Inc, Northstar Hlthcare, Oxford Pharms, Rubicon, Sun Pharm Inds Inc, Teva, Unichem, Upsher Smith Labs, Usl Pharma, Vintage Pharms, Watson Labs, and Zydus. and is included in thirty-five NDAs.
The generic ingredient in BACLOFEN is baclofen. There are twenty-one drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the baclofen profile page.
A generic version of BACLOFEN was approved as baclofen by IVAX SUB TEVA PHARMS on July 21st, 1988.
Summary for BACLOFEN
Recent Clinical Trials for BACLOFEN
Identify potential brand extensions & 505(b)(2) entrants
|Postgraduate Institute of Dental Sciences Rohtak||Phase 4|
|Fayoum University Hospital||Phase 4|
|University of Alabama at Birmingham||Phase 2/Phase 3|